Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 1512-1516, March 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myoga, A.
Right arrow Articles by Matsumoto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myoga, A.
Right arrow Articles by Matsumoto, M.

Detection of Patients with Cancer by Monoclonal Antibody Directed to Lactoneotetraosylceramide (Paragloboside)

Akio Myoga, Takao Taki1, Kenji Arai, Kiyoshi Sekiguchi, Isao Ikeda, Kunio Kurata and Makoto Matsumoto

Institute of Dainabot Co., Ltd., 344 Minorudai, Matsudo, Chiba 271 [A. M., K. S., I. I., K. K.], and Department of Biochemistry, School of Pharmaceutical Science, University of Shizuoka, 2-2-1 Oshika, Shizuoka 422 [T. T., K. A., M. M.], Japan

A hybridoma producing monoclonal antibody (H11) directed to lactoneotetraosylceramide (paragloboside) has been established from spleen cells of a mouse immunized with paragloboside. The monoclonal antibody H11 (immunoglobulin M type) was selected from five clones showing different reactivities with paragloboside. The monoclonal antibody was highly specific to paragloboside and lacked reactivity with other glycolipids including glucosylceramide, lactosylceramide, globotriaosylceramide, globotetraosylceramide, gangliotriaosylceramide, gangliotetraosylceramide, and GalNAcß1-4[NeuAc{alpha}2-3]Galß1-4Glcß1-1Cer. However, the monoclonal antibody (H11) was found to bind to lactosamine-containing glycolipids at their terminals, such as i- and I-type glycolipids as well as paragloboside. A two-step sandwich radioimmunoassay method for paragloboside antigen in serum was established by using the monoclonal antibody. The mean paragloboside antigen concentration in the sera from 20 normal individuals was 25.3 ng/ml. If the cutoff value was set at 80.9 ng/ml [25.3 + 2 x 27.8 (SD)], only 1 of 20 healthy controls had an elevated paragloboside value in the serum, whereas sera from 9 of 12 (75.0%) hepatoma, 4 of 10 (40%) pancreatic cancer, 16 of 40 (40.0%) stomach cancer, and 6 of 10 (60%) lung cancer patients had elevated paragloboside values. Sera from 3 of 8 hepatitis patients and 7 of 10 liver cirrhosis patients were estimated to be positive but sera from 16 patients with benign disease had paragloboside levels lower than the cutoff value. A larger amount of the antigen was found in liver metastases from colorectal carcinoma compared to the normal counterpart. The antigen was also detected in the medium of various human cancer cells and meconium. However, the antigen in the sera, medium, meconium, and cancer tissue seemed to be associated with glycoprotein or lipoprotein, because most of the antigen activity was eluted in the void volume fraction on high-performance liquid chromatography with a gel filtration column.

1 Recipient of Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan. To whom requests for reprints should be addressed.

Received 4/27/87. Revised 10/22/87. Accepted 12/ 4/87.




This article has been cited by other articles:


Home page
J BiochemHome page
C. Aoki, K. I.P.J. Hidari, S. Itonori, A. Yamada, N. Takahashi, T. Kasama, F. Hasebe, M. A. Islam, K. Hatano, K. Matsuoka, et al.
Identification and characterization of carbohydrate molecules in Mammalian cells recognized by dengue virus type 2.
J. Biochem., March 1, 2006; 139(3): 607 - 614.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W.-S. Chen, H.-Y. Chang, C.-P. Li, J. M. Liu, and T.-S. Huang
Tumor {beta}-1,4-Galactosyltransferase IV Overexpression Is Closely Associated with Colorectal Cancer Metastasis and Poor Prognosis
Clin. Cancer Res., December 15, 2005; 11(24): 8615 - 8622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Iwamura, K. Furukawa, M. Uchikawa, B. N. Sojka, Y. Kojima, J. Wiels, H. Shiku, T. Urano, and K. Furukawa
The Blood Group P1 Synthase Gene Is Identical to the Gb3/CD77 Synthase Gene: A CLUE TO THE SOLUTION OF THE P1/P2/p PUZZLE
J. Biol. Chem., November 7, 2003; 278(45): 44429 - 44438.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
T. Ichikawa, J. Nakayama, N. Sakura, T. Hashimoto, M. Fukuda, M. N. Fukuda, and T. Taki
Expression of N-acetyllactosamine and {beta}1,4-Galactosyltransferase ({beta}4GalT-I) During Adenoma-Carcinoma Sequence in the Human Colorectum
J. Histochem. Cytochem., December 1, 1999; 47(12): 1593 - 1602.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Terayama, T. Seiki, A. Nakamura, K. Matsumori, S. Ohta, S. Oka, M. Sugita, and T. Kawasaki
Purification and Characterization of a Glucuronyltransferase Involved in the Biosynthesis of the HNK-1 Epitope on Glycoproteins from Rat Brain
J. Biol. Chem., November 13, 1998; 273(46): 30295 - 30300.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Terayama, S. Oka, T. Seiki, Y. Miki, A. Nakamura, Y. Kozutsumi, K. Takio, and T. Kawasaki
Cloning and functional expression of a novel glucuronyltransferase involved in the biosynthesis of the carbohydrate epitope HNK-1
PNAS, June 10, 1997; 94(12): 6093 - 6098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Panjwani, Z. Zhao, S. Ahmad, Z. Yang, F. Jungalwala, and J. Baum
Neolactoglycosphingolipids, Potential Mediators of Corneal Epithelial Cell Migration
J. Biol. Chem., June 9, 1995; 270(23): 14015 - 14023.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.